REG - Hikma Pharmaceutical - Director/PDMR Shareholding <Origin Href="QuoteRef">HIK.L</Origin>
RNS Number : 3967SHikma Pharmaceuticals Plc20 December 2016Notification and public disclosure of transactions by persons discharging managerial responsibilities
The attached individual notification made under article 19.1 of the Market Abuse Regulation ("MAR") relates to the transfer of Ordinary Shares in Darhold Limited (which owns 25.00% of the Ordinary Shares of 10 pence each in Hikma Pharmaceuticals PLC ("Hikma")) from Mazen Darwazah to The TWMR Trust, a trust for the benefit of Mazen Darwazah and his family. This announcement is made in accordance with article 19.3 of MAR.
1
Details of the person discharging managerial responsibilities / person closely associated
a)
Name
Mazen Darwazah
2
Reason for the notification
a)
Position/status
Executive Vice Chairman / PDMR
b)
Initial notification /Amendment
Initial notification
3
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)
Name
Hikma Pharmaceuticals PLC ('Hikma')
b)
LEI
549300BNS685UXH4JI75
4
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)
Description of the financial instrument, type of instrument and identification code
Description: Ordinary shares of 10 pence each
ID Code: GB00B0LCW083
b)
Nature of the transaction
Transfer of 5,449,716 Ordinary Shares of Darhold Limited (who holds 25.00% of the issues share capital of Hikma) to The TWMR Trust, a trust for the benefit of Mazen Darwazah and members of his immediate family.
c)
Price(s) and volume(s)
Price(s): 0.00
Volume(s): 0
d)
Aggregated information
Aggregated volume: 0
Price: 0.00
e)
Date of the transaction
20 December 2016
f)
Place of the transaction
Jersey
Peter Speirs, Company Secretary, Responsible for releasing this announcement
20 December 2016
This information is provided by RNSThe company news service from the London Stock ExchangeENDDSHBUBDDXDDBGLG
Recent news on Hikma Pharmaceuticals
See all newsREG - Hikma Pharmaceutical - Transaction in Own Shares
AnnouncementREG - Hikma Pharmaceutical - Transaction in Own Shares
AnnouncementREG - Hikma Pharmaceutical - Transaction in Own Shares
AnnouncementREG - Hikma Pharmaceutical - Transaction in Own Shares
AnnouncementREG - Hikma Pharmaceutical - Transaction in Own Shares
Announcement